Fetal Corpus Callosum Anomalies: A Review of Underlying Genetic Disorders and Prenatal Testing Options.

Anomalies of the corpus callosum (CC) are amongst the most common fetal Central Nervous System (CNS) anomalies detectable on ultrasound. Underlying genetic disease plays an important part in defining prognosis. Associations with aneuploidy and submicroscopic chromosomal deletions or duplications have been well demonstrated using chromosomal microarray analysis.

Systematic ultrasound evaluation of olfactory sulci in fetuses with congenital heart defects: a clue for CHARGE syndrome diagnosis.

Objectives: This study aimed to assess the role of olfactory sulci (OS) in diagnosing CHARGE syndrome among fetuses with major congenital heart defects (CHDs).

Methods: We prospectively evaluated OS development in fetuses diagnosed with CHDs from 2017 to 2021. Neurosonography (NSG) was performed using transabdominal and transvaginal approaches after 30 weeks of gestation.

Characterization of plastic ingestion in urban gull chicks and its implications for their use as pollution sentinels in coastal cities.

The increase of plastic pollution represents a significant ecological threat, particularly in human-impacted environments. However, the effects of plastic ingestion by urban wildlife are less understood. This study investigates the presence of microplastic (MPs; plastic <5 mm in size) and macroplastics (MaPs, plastic >5 mm in size) in yellow-legged gull (Larus michahellis) chicks inhabiting the urban marine ecosystem of Barcelona (northeastern Spain).

Prenatal Screening of Chromosomal Anomalies Using Genome-Wide or Target Cell-Free DNA: Preferences and Satisfaction of Pregnant Women.

: Cell-free DNA (cfDNA) is a non-invasive prenatal test used to screen for common trisomies (target cfDNA) that can be expanded to assess all autosomal chromosomes (genome-wide cfDNA). As cfDNA testing gains popularity, it is crucial to examine the factors influencing the decision-making process of pregnant individuals when choosing between these two approaches. : In this prospective cohort study, 190 individuals undergoing cfDNA testing for aneuploidy screening, according to the current screening protocol, were allowed to make their own choice between target and genome-wide cfDNA testing.